A Review of the Effect of COVID-19-Related Lockdowns on Global Cancer Screening

COVID-19 lockdowns have led to significant disruptions in preventative health services worldwide. This review aims to assess the impact of COVID-19 lockdowns on worldwide preventive cancer screening participation. Major medical databases were searched using the keywords ‘lockdown,’ ‘cancer,’ and ‘screening or diagnosis,’ and relevant articles were evaluated against inclusion and exclusion criteria. The final review consisted of 38 studies. The impact of COVID-19 on screening uptake was categorized based on cancer type. All types of screening had decreased participation during or around the lockdown period. Racial and socioeconomic disparities, provider-related barriers, and patient attitudes about service disruptions during the pandemic were also highlighted in this review. Future research should focus on data from low- and middle-income countries to obtain a more comprehensive picture of the problem. Policy interventions that adopt self-screening or different screening intervals can also be considered to reduce impacts in future crises. Insights from existing studies and future research will allow for more proactive measures to manage future disruptions.

[1]  Renee Williams,et al.  Impact of the COVID-19 pandemic on colorectal cancer screening in New York City , 2022, Journal of medical screening.

[2]  P. Boffetta,et al.  Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. , 2022, JAMA oncology.

[3]  D. Hamilton,et al.  Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis , 2022, Journal of medical screening.

[4]  C. Mercer,et al.  How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID) , 2022, Sexually Transmitted Infections.

[5]  N. Ravishankar,et al.  The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis , 2022, Asian Pacific journal of cancer prevention : APJCP.

[6]  Prashanth Rawla,et al.  US Cancer Screening Recommendations: Developments and the Impact of COVID-19 , 2022, Medical sciences.

[7]  S. le Cessie,et al.  Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators , 2022, BMC cancer.

[8]  H. Goyal,et al.  Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions , 2022, Medicina.

[9]  Vijay Kumar Chattu,et al.  Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 , 2021, JAMA oncology.

[10]  S. Leeson,et al.  Early Welsh cervical screening programme learning as a consequence of the coronavirus pandemic , 2021, Cytopathology : official journal of the British Society for Clinical Cytology.

[11]  Andreea Ardelean,et al.  Feasibility of HPV self-sampling pathway in Kathmandu Valley, Nepal using a human-centred design approach , 2021, Sexual and reproductive health matters.

[12]  J. Warner,et al.  Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. , 2021, Cancer discovery.

[13]  Incidence and relative survival by stage at diagnosis for common cancers , 2021 .

[14]  J. Morling,et al.  The impact of COVID-19 on national screening programmes in England , 2021, Public Health.

[15]  Laura Martínez,et al.  The impact of the COVID-19 pandemic on cancer care in the public health subsector, province of Santa Fe, Argentina , 2021, Ecancermedicalscience.

[16]  D. Grozeva,et al.  Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study , 2021, Preventive Medicine.

[17]  L. Rabeneck,et al.  Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study , 2021, Preventive Medicine.

[18]  W. Helsel,et al.  COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States , 2021, Preventive Medicine.

[19]  L. Rabeneck,et al.  Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey , 2021, Preventive Medicine.

[20]  J. Haas,et al.  The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis , 2021, Preventive Medicine.

[21]  H. Verkooijen,et al.  Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic , 2021, Preventive Medicine.

[22]  Bülent Koca,et al.  Delay in breast cancer diagnosis and its clinical consequences during the coronavirus disease pandemic , 2021, Journal of surgical oncology.

[23]  A. Nessa,et al.  Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme – A case study from Bangladesh , 2021, Preventive Medicine.

[24]  E. Giovannucci,et al.  Has COVID-19 Affected Cancer Screening Programs? A Systematic Review , 2021, Frontiers in Oncology.

[25]  E. Osei,et al.  Impact of COVID-19 pandemic on the oncologic care continuum: urgent need to restore patients care to pre-COVID-19 era , 2021, Journal of Radiotherapy in Practice.

[26]  H. Verkooijen,et al.  Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study , 2021, Journal of Hematology & Oncology.

[27]  M. Primic Žakelj,et al.  The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry , 2021, The Lancet regional health. Europe.

[28]  D. Miglioretti,et al.  Changes in Mammography Utilization by Women’s Characteristics during the First 5 Months of the COVID-19 Pandemic , 2021, Journal of the National Cancer Institute.

[29]  M. Poljak,et al.  Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening. , 2021, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[30]  L. Henderson,et al.  Population‐level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures , 2021, Cancer.

[31]  G. Lippi,et al.  Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak , 2021, EJIFCC.

[32]  B. Mittman,et al.  Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[33]  S. Lipsitz,et al.  Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. , 2021, JAMA oncology.

[34]  Hannah Masson.  Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve , 2021, Women's health.

[35]  Shimul A. Shah,et al.  Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer , 2020, Journal of the American College of Surgeons.

[36]  Ari B. Friedman,et al.  Disruptions in preventive care: Mammograms during the COVID-19 pandemic. , 2020, Health services research.

[37]  D. Patt,et al.  Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors , 2020, JCO clinical cancer informatics.

[38]  J. Brill.  Screening for cancer: the economic, medical, and psychosocial issues. , 2020, The American journal of managed care.

[39]  F. Jacobson,et al.  Deferral and Resumption of Lung Cancer Screening After COVID-19 Surge: Patient Perspectives From Two Institutions , 2020, Journal of the American College of Radiology.

[40]  K. Hughes,et al.  Breast imaging, breast surgery, and cancer genetics in the age of COVID‐19 , 2020, Cancer.

[41]  L. Sharp,et al.  Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis , 2020, Gut.

[42]  M. Zorzi,et al.  Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses. , 2022, Annali dell'Istituto superiore di sanita.